Dhavit Global Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-12-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 7.50 M
as on 16-12-2024
- Revenue %
(FY 2020)
- Profit -20.24%
(FY 2020)
- Ebitda -18.20%
(FY 2020)
- Net Worth 1501.23%
(FY 2020)
- Total Assets 20.83%
(FY 2020)
About Dhavit Global Life Sciences
The Corporate was formerly known as Dhavit Industries India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.50 M.
Surekha Katgaon, Suresh Katgaon, Appasha Umadi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24304PN2018PTC174438
- Company No.
174438
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dhavit Global Life Sciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Savarkar  | Director | 01-Jun-2020 | Current |
| Milind Kulkarni | Director | 01-Jun-2020 | Current |
| Surekha Katgaon | Director | 18-Jan-2018 | Current |
| Suresh Katgaon | Director | 18-Jan-2018 | Current |
| Appasha Umadi | Additional Director | 01-Jun-2020 | Current |
| Hariharan Rajeev | Additional Director | 01-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Dhavit Global Life Sciences.
Dhavit Global Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 20.24% decrease in profit. The company's net worth Soared by an impressive increase of 1501.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhavit Global Life Sciences?
In 2020, Dhavit Global Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yes Telecom India Private LimitedActive 14 years 7 monthsSurekha Katgaon and Suresh Katgaon are mutual person
9 Id Innovations India LlpActive 1 year 10 monthsSurekha Katgaon and Suresh Katgaon are mutual person
- Solapur Care Multispecialty Hospital & Research Center Private LimitedActive 9 years 4 months
Appasha Umadi is a mutual person
- Primecare Multispeciality Hospital And Research Center Private LimitedActive 1 year 7 months
Appasha Umadi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 29 Aug 2020 | ₹7.50 M | Open |
How Many Employees Work at Dhavit Global Life Sciences?
Unlock and access historical data on people associated with Dhavit Global Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhavit Global Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhavit Global Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
